Guangzhou Jet Bio-Filtration Co., Ltd. (SHA:688026)
China · Delayed Price · Currency is CNY 15.10
+2.10 (16.15%)
Jun 18, 2026, 3:00 PM CST
SHA:688026 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 549.4 | 532.64 | 530.82 | 449.41 | 603.62 | 847.18 |
Other Revenue | - | 31.34 | 27.84 | 13.69 | 6.2 | 8.48 |
| 549.4 | 563.98 | 558.66 | 463.1 | 609.82 | 855.66 | |
Revenue Growth (YoY) | -5.96% | 0.95% | 20.64% | -24.06% | -28.73% | 69.80% |
Cost of Revenue | 504.12 | 334.06 | 332.54 | 327.18 | 431.23 | 508.24 |
Gross Profit | 45.28 | 229.91 | 226.11 | 135.91 | 178.59 | 347.42 |
Selling, General & Admin | 5.43 | 91.95 | 79.74 | 58.33 | 56.49 | 59.69 |
Research & Development | 1.23 | 29.12 | 26.25 | 28.51 | 37.34 | 43.84 |
Other Operating Expenses | -0.12 | 9.21 | 6.94 | 6.67 | 7.53 | 3.51 |
Operating Expenses | 7.31 | 129.36 | 116.71 | 96.46 | 99.9 | 110.35 |
Operating Income | 37.97 | 100.55 | 109.4 | 39.46 | 78.69 | 237.07 |
Interest Expense | -0.44 | -28.25 | -26.44 | -24.79 | -12.85 | -1.09 |
Interest & Investment Income | 1.2 | 10.32 | 14.52 | 14.38 | 8.14 | 6.83 |
Currency Exchange Gain (Loss) | - | -2.16 | -0.46 | 5.45 | 12.05 | -9.6 |
Other Non Operating Income (Expenses) | -6.22 | 6.21 | -0.17 | -0.11 | 8.06 | -10.84 |
EBT Excluding Unusual Items | 32.52 | 86.67 | 96.86 | 34.38 | 94.1 | 222.36 |
Gain (Loss) on Sale of Investments | 0.27 | -26.06 | -1 | -0.8 | -1.67 | - |
Gain (Loss) on Sale of Assets | 0.01 | -1.35 | -0.17 | -1.81 | 0.47 | 0 |
Asset Writedown | 3.66 | -3.21 | -5.46 | -0.53 | -9.02 | -22.93 |
Legal Settlements | - | - | -0.1 | - | - | - |
Other Unusual Items | 0.02 | 4.88 | 5.5 | 7.07 | 14.13 | -3.78 |
Pretax Income | 36.48 | 60.93 | 95.62 | 38.32 | 98 | 195.65 |
Income Tax Expense | 9.43 | 11.84 | 19.2 | 3.22 | 10.31 | 24.49 |
Earnings From Continuing Operations | 27.05 | 49.09 | 76.42 | 35.1 | 87.69 | 171.16 |
Minority Interest in Earnings | 0.48 | -0.86 | -0.77 | -0.31 | 0.02 | - |
Net Income | 27.53 | 48.24 | 75.65 | 34.79 | 87.71 | 171.16 |
Net Income to Common | 27.53 | 48.24 | 75.65 | 34.79 | 87.71 | 171.16 |
Net Income Growth | -65.79% | -36.23% | 117.44% | -60.34% | -48.75% | 43.38% |
Shares Outstanding (Basic) | 139 | 138 | 138 | 139 | 139 | 140 |
Shares Outstanding (Diluted) | 139 | 138 | 138 | 139 | 139 | 140 |
Shares Change (YoY) | -3.66% | 0.20% | -1.16% | -0.05% | -0.76% | 2.41% |
EPS (Basic) | 0.20 | 0.35 | 0.55 | 0.25 | 0.63 | 1.22 |
EPS (Diluted) | 0.20 | 0.35 | 0.55 | 0.25 | 0.63 | 1.22 |
EPS Growth | -64.49% | -36.36% | 120.00% | -60.32% | -48.36% | 40.01% |
Free Cash Flow | - | 67.71 | -56.72 | -48.91 | -7 | -57.54 |
Free Cash Flow Per Share | - | 0.49 | -0.41 | -0.35 | -0.05 | -0.41 |
Dividend Per Share | 0.074 | 0.074 | 0.073 | 0.072 | 0.071 | 0.429 |
Dividend Growth | 1.37% | 1.37% | 0.97% | 1.49% | -83.38% | 400.12% |
Gross Margin | 8.24% | 40.77% | 40.47% | 29.35% | 29.29% | 40.60% |
Operating Margin | 6.91% | 17.83% | 19.58% | 8.52% | 12.90% | 27.71% |
Profit Margin | 5.01% | 8.55% | 13.54% | 7.51% | 14.38% | 20.00% |
Free Cash Flow Margin | - | 12.01% | -10.15% | -10.56% | -1.15% | -6.72% |
EBITDA | - | 154.31 | 170.4 | 97.95 | 132.51 | 280.82 |
EBITDA Margin | - | 27.36% | 30.50% | 21.15% | 21.73% | 32.82% |
D&A For EBITDA | - | 53.75 | 61 | 58.5 | 53.82 | 43.74 |
EBIT | 37.97 | 100.55 | 109.4 | 39.46 | 78.69 | 237.07 |
EBIT Margin | 6.91% | 17.83% | 19.58% | 8.52% | 12.90% | 27.71% |
Effective Tax Rate | 25.85% | 19.43% | 20.08% | 8.41% | 10.52% | 12.52% |
Revenue as Reported | - | 563.98 | 558.66 | 463.1 | 609.82 | 855.66 |
Advertising Expenses | - | 3.62 | 4 | 4.74 | 2.7 | 3.02 |